Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation

We present a case report of a 40-year-old Caucasian man who was diagnosed with type 2 diabetes mellitus at the age of 27. In his case, the patient took oral hypoglycemic drugs for 6 months, but then insulin therapy was started because glycemic goals were not achieved. In order to verify the right ty...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Vetrova, M. M. Orlova, N. E. Kolobanova
Format: Article
Language:Russian
Published: Open Systems Publication 2023-04-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1030
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839591400991096832
author A. V. Vetrova
M. M. Orlova
N. E. Kolobanova
author_facet A. V. Vetrova
M. M. Orlova
N. E. Kolobanova
author_sort A. V. Vetrova
collection DOAJ
description We present a case report of a 40-year-old Caucasian man who was diagnosed with type 2 diabetes mellitus at the age of 27. In his case, the patient took oral hypoglycemic drugs for 6 months, but then insulin therapy was started because glycemic goals were not achieved. In order to verify the right type of diabetes after 6 years of the onset of disease, the patient was tested on the main immunological and genetic markers of diabetes mellitus. This observation period clearly demonstrated the "typical" course of LADA. The main signs of LADA are – gradual decreasing in the level of C-peptide, starting insulin therapy after 6 months from the onset of diabetes. LADA is associates with positive autoimmune markers (GAD-antibodies) in blood samples. In the case of our patient we saw the "classical" development of LADA. According to modern datas, pathogenesis of different types of diabetes is based on multiple variants of β-cell damage, which can lead to unique course of treatment and manifestation of macroand microvascular complications. It means that different gene combination can cause clinical symptoms of diabetes which can not be classified only on 1 or 2 type of diabetes. The idea of "hybrid" forms of diabetes has long attracted attention, since their pathogenesis may be based on various types of damage to β-cells, which affects the course, prognosis, and clinical tactics. On the one side we see typical LADA signs. On the other case, physicians wanted to see the prognosis of the disease, especially predict the same case of LADA in patient’s family. The patient underwent genetic testing for 9 main genes, mutations in which are responsible for predisposition to obesity and type 2 diabetes. According to the results of this study, the patient had a heterozygous mutation in the genes: TCF7L2, CDKAL1, CDKN2A/2B. The patient revealed a hybrid form of LADA, combining both immunological markers of LADA (positive antibodies to GAD), as well as genetic markers of type 2 diabetes mellitus (mutation in the genes TCF7L2, CDKAL1, CDKN2A/2B). The number of patients with the onset of diabetes mellitus at a young age and the absence of a sign of absolute insulin deficiency are increasing. Genetic, immunological tests can help patients to achieve glycemic goals and prevent macroand microvascular complications
format Article
id doaj-art-c06850d066924d8587740a9c29961010
institution Matheson Library
issn 1560-5175
2687-1181
language Russian
publishDate 2023-04-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-c06850d066924d8587740a9c299610102025-08-03T13:02:55ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-04-0103141710.51793/OS.2023.26.3.0021025Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observationA. V. Vetrova0M. M. Orlova1N. E. Kolobanova2State Autonomous Healthcare Institution Engels City Clinical Hospital No. 1Federal State Budgetary Educational Institution of Higher Education V. I. Razumovsky Saratov State Medical University of the Ministry of Health of the Russian FederationState Healthcare Institution Saratov City Clinical Hospital No. 9We present a case report of a 40-year-old Caucasian man who was diagnosed with type 2 diabetes mellitus at the age of 27. In his case, the patient took oral hypoglycemic drugs for 6 months, but then insulin therapy was started because glycemic goals were not achieved. In order to verify the right type of diabetes after 6 years of the onset of disease, the patient was tested on the main immunological and genetic markers of diabetes mellitus. This observation period clearly demonstrated the "typical" course of LADA. The main signs of LADA are – gradual decreasing in the level of C-peptide, starting insulin therapy after 6 months from the onset of diabetes. LADA is associates with positive autoimmune markers (GAD-antibodies) in blood samples. In the case of our patient we saw the "classical" development of LADA. According to modern datas, pathogenesis of different types of diabetes is based on multiple variants of β-cell damage, which can lead to unique course of treatment and manifestation of macroand microvascular complications. It means that different gene combination can cause clinical symptoms of diabetes which can not be classified only on 1 or 2 type of diabetes. The idea of "hybrid" forms of diabetes has long attracted attention, since their pathogenesis may be based on various types of damage to β-cells, which affects the course, prognosis, and clinical tactics. On the one side we see typical LADA signs. On the other case, physicians wanted to see the prognosis of the disease, especially predict the same case of LADA in patient’s family. The patient underwent genetic testing for 9 main genes, mutations in which are responsible for predisposition to obesity and type 2 diabetes. According to the results of this study, the patient had a heterozygous mutation in the genes: TCF7L2, CDKAL1, CDKN2A/2B. The patient revealed a hybrid form of LADA, combining both immunological markers of LADA (positive antibodies to GAD), as well as genetic markers of type 2 diabetes mellitus (mutation in the genes TCF7L2, CDKAL1, CDKN2A/2B). The number of patients with the onset of diabetes mellitus at a young age and the absence of a sign of absolute insulin deficiency are increasing. Genetic, immunological tests can help patients to achieve glycemic goals and prevent macroand microvascular complicationshttps://journal.lvrach.ru/jour/article/view/1030diabetes mellitustherapyendocrinologylatent autoimmune diabetes in adultsmutationshybrid diabetes
spellingShingle A. V. Vetrova
M. M. Orlova
N. E. Kolobanova
Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
Лечащий Врач
diabetes mellitus
therapy
endocrinology
latent autoimmune diabetes in adults
mutations
hybrid diabetes
title Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
title_full Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
title_fullStr Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
title_full_unstemmed Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
title_short Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
title_sort hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity сlinical observation
topic diabetes mellitus
therapy
endocrinology
latent autoimmune diabetes in adults
mutations
hybrid diabetes
url https://journal.lvrach.ru/jour/article/view/1030
work_keys_str_mv AT avvetrova hybriddiabetesinapatientwithlatentautoimmunediabetesinadultsandgeneticmarkersofpredispositiontotype2diabetesandobesityslinicalobservation
AT mmorlova hybriddiabetesinapatientwithlatentautoimmunediabetesinadultsandgeneticmarkersofpredispositiontotype2diabetesandobesityslinicalobservation
AT nekolobanova hybriddiabetesinapatientwithlatentautoimmunediabetesinadultsandgeneticmarkersofpredispositiontotype2diabetesandobesityslinicalobservation